Clinical characteristics associated with VTE in bivariate analyses
| Characteristic . | Odds ratio . | 95% CI . | P . |
|---|---|---|---|
| Age, for each 1-y increase | 0.99 | 0.97-1.01 | .32 |
| Race, nonwhite relative to white | 0.99 | 0.70-1.41 | .97 |
| Sex, female compared with male | 1.57 | 0.96-2.56 | .07 |
| Disease category, heme vs solid | 0.96 | 0.48-1.92 | .92 |
| Year of transplantation, for every 1-y increase | 0.97 | 0.91-1.04 | .46 |
| Duration of hospitalization, for every additional day | 1.01 | 1.00-1.03 | .05* |
| Overall survival, for every additional day | 1.00 | 1.00-1.00 | .22 |
| Prior VTE | 8.36 | 2.62-21.0 | <.001* |
| Type of transplantation, autologous vs allogeneic | 0.89 | 0.58-1.54 | .82 |
| Complications of transplantation | |||
| GVHD | 2.05 | 1.22-3.45 | .006* |
| VOD | 0.86 | 0.31-2.41 | .77 |
| CMV | 1.00 | 0.36-2.82 | .99 |
| Immune modulators | |||
| Cyclosporine | 1.26 | 0.78-2.04 | .34 |
| Corticosteroids | 1.87 | 1.09-3.14 | .02* |
| Characteristic . | Odds ratio . | 95% CI . | P . |
|---|---|---|---|
| Age, for each 1-y increase | 0.99 | 0.97-1.01 | .32 |
| Race, nonwhite relative to white | 0.99 | 0.70-1.41 | .97 |
| Sex, female compared with male | 1.57 | 0.96-2.56 | .07 |
| Disease category, heme vs solid | 0.96 | 0.48-1.92 | .92 |
| Year of transplantation, for every 1-y increase | 0.97 | 0.91-1.04 | .46 |
| Duration of hospitalization, for every additional day | 1.01 | 1.00-1.03 | .05* |
| Overall survival, for every additional day | 1.00 | 1.00-1.00 | .22 |
| Prior VTE | 8.36 | 2.62-21.0 | <.001* |
| Type of transplantation, autologous vs allogeneic | 0.89 | 0.58-1.54 | .82 |
| Complications of transplantation | |||
| GVHD | 2.05 | 1.22-3.45 | .006* |
| VOD | 0.86 | 0.31-2.41 | .77 |
| CMV | 1.00 | 0.36-2.82 | .99 |
| Immune modulators | |||
| Cyclosporine | 1.26 | 0.78-2.04 | .34 |
| Corticosteroids | 1.87 | 1.09-3.14 | .02* |
indicates statistically significant.